Showing 8 of 8 recruiting trials for “hiv-associated-cancer”
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
👨⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2026View details ↗
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
👨⚕️ Sue Yom, MD, PhD, University of California, San Francisco📍 1 site📅 Started Mar 2025View details ↗
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
👨⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Dec 2021View details ↗
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
👨⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Sep 2021View details ↗
ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
👨⚕️ Allen Yeoh, M.D, National University Hospital, Singapore📍 1 site📅 Started Apr 2021View details ↗
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
👨⚕️ Zhenfeng Zhang, MD,PhD, Second Affiliated Hospital of Guangzhou Medical University📍 2 sites📅 Started Jul 2017View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →